Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Proximal Ventures is a venture capital firm founded by Sahir Raoof, who brings over a decade of experience in pharmatech and techbio. The firm is headquartered in the United States and is dedicated to investing in the life sciences sector. Raoof's background as both an operator and investor provides a unique perspective on the challenges and opportunities within this field.
Since its inception, Proximal Ventures has focused on early-stage investments, particularly in pre-seed and seed rounds. The firm aims to support innovative companies that are developing cutting-edge solutions in biotechnology, healthcare, and artificial intelligence. Proximal Ventures is committed to fostering growth in these critical sectors, which are essential for advancing human health and well-being.
Proximal Ventures concentrates its investment strategy on the life sciences sector, with a particular emphasis on companies that are developing AI and infrastructure solutions. The firm typically invests in the pre-seed and seed stages, providing funding that ranges from $500,000 to $1,000,000. This financial support is aimed at helping startups establish their foundations and accelerate their growth.
The firm seeks to partner with visionary founders who are addressing significant challenges in healthcare and biotechnology. Proximal Ventures looks for innovative ideas that leverage technology to improve patient outcomes and streamline healthcare processes. Their investment thesis is rooted in the belief that advancements in AI and infrastructure can lead to transformative changes in the life sciences.
Sahir Raoof - Founder and Managing Partner. Raoof has over a decade of experience in pharmatech and techbio, having worked as both an operator and investor. His expertise lies in identifying and supporting innovative companies in the life sciences sector.
To pitch Proximal Ventures, founders should send an email to info@proximal.vc with a comprehensive pitch deck. The deck should include details about the startup's vision, market analysis, and team credentials. Founders can expect a response within a reasonable timeframe, though specific timelines are not disclosed.
What are Proximal Ventures' investment criteria?
Proximal Ventures invests in early-stage companies within the life sciences sector, focusing on those developing AI and infrastructure solutions. They primarily target pre-seed and seed stage startups.
How can founders pitch to Proximal Ventures?
Founders can reach out to Proximal Ventures via email at info@proximal.vc. It is advisable to include a detailed pitch deck that outlines the business model, market opportunity, and team background.
What makes Proximal Ventures different from other investors?
Proximal Ventures is distinct in its focus on the intersection of AI and life sciences, leveraging Sahir Raoof's extensive experience in pharmatech and techbio to identify promising startups that can drive innovation in healthcare.
What is the typical check size for investments?
The firm typically invests between $500,000 and $1,000,000 in each startup, providing substantial support for early-stage companies.
What geographic areas does Proximal Ventures focus on?
Proximal Ventures primarily invests in companies based in the United States, aligning with their goal to support local innovation in the life sciences sector.
What kind of post-investment involvement can founders expect?
While specific details on post-investment involvement are not provided, Proximal Ventures aims to support its portfolio companies through strategic guidance and leveraging Sahir Raoof's industry expertise.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.